Employer-Paid

The company expects to file for regulatory approval of a label expansion for Ozempic pills in the United States and Rybelsus in the European Union in the second half of this year.

That change could create new ways for plan employers to get into trouble.

Brokers "provide an incredibly valuable service," but "we've got to be able to trust them," James Gelfand testified.

Elevance, Anthem's parent, hopes simpler plans and AI will moderate the impact of cost cuts.

"The reclassification of errors raises the stakes of inspections in an already aggressive enforcement environment," wrote attorneys from employment law firm Littler on the update.

A top insurance industry risk math expert has designed two new ETFs for that purpose.